GlassScriptPhysician profile
Paul L Goodman
NPI 1295781433
$12,753.54
in general payments reported to CMS, 2019-2025
37 companies · $1,132 in 2025
The $1,132 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,069 · 2020: $1,242 · 2021: $248 · 2022: $1,529 · 2023: $2,036 · 2024: $5,498 · 2025: $1,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,153 · Consulting Fee: $3,600 · Travel and Lodging: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,152.59 |
| Consulting Fee | $3,600.00 |
| Travel and Lodging | $912.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $4,143.65 | 2024-2025 | |
| Smith+Nephew, INC. | $1,331.32 | 2020-2025 | Bone Anchors With Arthroscopic Delivery System, Footprint, Evos Mini |
| Zimmer Biomet Holdings, INC. | $1,047.71 | 2019-2022 | |
| Treace Medical Concepts, INC. | $1,006.22 | 2023-2025 | |
| Stryker Corporation | $690.65 | 2022-2025 | Augment Injectable, Ortholoc 2 Lapifuse, Hoffmann |
| Wright Medical Technology, INC. | $521.51 | 2019-2020 | |
| Medartis INC. | $464.68 | 2022-2023 | Aptus |
| Acera Surgical, INC. | $400.89 | 2019-2024 | Restrata Wound Matrix |
| Nextremity Solutions INC. | $391.34 | 2019-2020 | |
| Trice Medical, INC. | $372.67 | 2022-2023 | |
| Bone Support INC. | $364.64 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Depuy Synthes Sales INC. | $292.95 | 2023-2025 | Motoband, Na |
| Next Science LLC | $185.89 | 2024 | Blastx, Xperience, Surgx |
| Medwest Associates | $155.69 | 2022 | |
| Kerecis Limited | $155.56 | 2020-2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.